Bladder Cancer - Results from #9120

5-azacytidine reverses drug resistance in bladder cancer cells January 9, 2012

Current management of muscle-invasive bladder cancer - Abstract January 9, 2012

Disparities in bladder cancer - Abstract January 9, 2012

Upper urinary tract recurrence after radical cystectomy for bladder cancer: Incidence and risk factors - Abstract January 6, 2012

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: Results for 778 patients from a hospital haematuria clinic - Abstract January 6, 2012

Urinary human polyomavirus and papillomavirus infection and bladder cancer risk - Abstract January 5, 2012

Current treatment of metastatic bladder cancer and future directions - Abstract January 5, 2012

The dilemma of cystectomy in old-old and oldest-old patients - Abstract January 5, 2012

Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years? - Abstract January 5, 2012

Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade - Abstract January 3, 2012

Chemotherapy for bladder cancer in patients with impaired renal function - Abstract December 23, 2011

Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology - Abstract December 22, 2011

Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin - Abstract December 21, 2011

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: The MGH experience - Abstract December 20, 2011

Invasive bladder cancer with concomitant carcinoma in situ treated with chemoradiotherapy followed by BCG intravesical infusion therapy to preserve the bladder : Report of three cases - Abstract December 15, 2011

Selective organ preservation in muscle-invasive bladder cancer: Review of the literature - Abstract December 14, 2011

Influence of renal excretory function on the performance of urine based markers to detect bladder cancer - Abstract December 14, 2011

Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study - Abstract December 13, 2011

Antitumor efficacy of intravesical BCG, gemcitabine, interferon-α and interleukin-2 as mono- or combination-therapy for bladder cancer in an orthotopic tumor model - Abstract December 12, 2011

Metastatic bladder cancer: A review of current management - Abstract December 12, 2011

Page 457 of 476